They have been doing good things all along. Same pathway as Trofinetide which has proven successful.
The SP will recover at some point if they just keep relentlessly creating value. As soon as Trofinetide passes P3 it will be happy days - it will also add a lot of credibility to Neuren and their technology which should see more support for NNZ-2591 and perhaps an earlier licencing deal. Again you would have to think NNZ-2591 meets the strategic objectives of Acadia in NA.
They have been doing good things all along. Same pathway as...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |